Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Clinical trial NCT04168528 · TERMINATED

Trial details

NCT number: NCT04168528
Sponsor: Universitair Ziekenhuis Brussel
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Solid Tumor Breast Cancer Melanoma (Skin)

Start date: 2019-11-05
Primary completion: 2024-12-04
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.